Nutra MED Packaging Llc Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Nutra MED Packaging Llc Pharmaceutical Import Records from India — 3 Products, $1.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Nutra MED Packaging Llc — Pharmaceutical Importer Profile (2026) | 3 Products, $1.4M Trade | TransData Nexus

Nutra MED Packaging Llc

Pharmaceutical Importer · United States · Respiratory Focus · $1.4M Total Trade · DGFT Verified

Nutra MED Packaging Llc is a pharmaceutical importer based in United States with a total trade value of $1.4M across 3 products in 2 therapeutic categories. Based on 27 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Nutra MED Packaging Llc sources from 1 verified Indian supplier, with Par Formulations Private Limited accounting for 100.0% of imports.

Nutra MED Packaging Llc — Import Portfolio & Supplier Network

Nutra MED Packaging Llc import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Nutra MED Packaging Llc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Par Formulations Private Limited	$937.8K	19	100.0%

Nutra MED Packaging Llc sources from 1 verified Indian supplier across 11 distinct formulations. The sourcing is highly concentrated — Par Formulations Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Nutra MED Packaging Llc Import?

Formulation	Value	Ships
Methylprednisolone 4MG TAB (50000) po	$150.0K	3
Methylprednisolone 4MG TAB 50000po	$150.0K	3
Prednisone tablets USP 5MG 50000po	$137.8K	3
Methylperdnisolone 4MG TAB(50,000) po no- 4500054508 po date -april 28	$100.0K	2
Methylprednisolone 4MG TAB (50000) po no:4500054513 - po date : april	$100.0K	2
Prednisone tablets USP 5 MG (50000) pono:4500054511 - po date : april	$50.0K	1
Prednisonee tablets USP 5 MG (50000) pono:4500054511 - po date : april	$50.0K	1
Prednisone tablets USP 10 MG (25000) pono:4500055379 - po date : may	$50.0K	1
Methylprednisolone 4MG TAB(50000) po no: 4500058768 po dt-april	$50.0K	1
Prednisone tablets USP 10 MG(25000) pono : 4500058757 po dt-april	$50.0K	1
Methylprednisolone 4MG TAB(50000) po no: 4500058768 po dt-april	$50.0K	1

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Methylprednisolone	Corticosteroids	$500.0K	10	1.7%	5
2	Prednisolone	Respiratory	$500.0K	10	0.5%	13
3	Prednisone	Respiratory	$350.0K	7	1.3%	9

Nutra MED Packaging Llc imports 3 pharmaceutical products across 2 categories into United States totaling $1.4M.

Nutra MED Packaging Llc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Nutra-Med Packaging LLC, established in 1999, is a privately held contract packaging company headquartered in Whippany, New Jersey. The company specializes in providing packaging services for pharmaceutical, over-the-counter (OTC), medical device, diagnostics, and dietary supplement industries across the United States and Canada. Their service offerings include blister packaging, bottling, specialized kitting, cartoning, and serialization operations for various dosage forms and devices.

The company operates four facilities within a half-mile radius in Whippany, NJ, encompassing a total of 215,000 square feet. These facilities are FDA registered, cGMP compliant, and licensed for DEA schedule III-V and L1 Chemical substances. Nutra-Med Packaging employs a diverse team of over 500 professionals, with one-third dedicated to quality control, ensuring adherence to stringent industry standards.

In January 2026, Hany Salama joined Nutra-Med Packaging as Chief Executive Officer, bringing over 20 years of global experience in healthcare, biopharma, consumer health, and life sciences. His leadership aims to drive the company's strategic vision, growth initiatives, and operational execution.

2Distribution Network

Nutra-Med Packaging LLC operates four facilities within a half-mile radius in Whippany, New Jersey, encompassing a total of 215,000 square feet. These facilities include 50,000 square feet dedicated to production and 123,000 square feet for finished goods, bulk, and component warehousing. The company offers 80 pallet cold chain storage at 2°C to 8°C, 29 temperature-controlled packaging suites, 11 blister packaging lines, 10 high-speed bottling lines, and 8 cartoning lines.

While the primary operations are based in New Jersey, Nutra-Med Packaging's services extend across the United States and Canada, catering to a diverse clientele in the pharmaceutical and healthcare sectors. The company's strategic location and comprehensive facilities enable efficient distribution and packaging solutions for its partners.

3Industry Role

Nutra-Med Packaging LLC serves as a contract packaging provider within the United States pharmaceutical supply chain. By offering services such as blister packaging, bottling, kitting, and serialization, the company plays a crucial role in ensuring that pharmaceutical products are packaged according to regulatory standards and are ready for distribution. This positions Nutra-Med Packaging as an intermediary between pharmaceutical manufacturers and end-users, facilitating the efficient delivery of pharmaceutical products to the market.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Nutra MED Packaging Llc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Nutra-Med Packaging LLC's sourcing strategy reveals a significant concentration with a single supplier, PAR Formulations Private Limited, accounting for 100% of their imports from India. This exclusive relationship indicates a high level of dependency on one supplier for their pharmaceutical packaging needs. The stability of this relationship is evidenced by 19 shipments valued at $938,000, suggesting a consistent and reliable partnership. However, such concentration may pose risks related to supply chain disruptions, pricing negotiations, and potential vulnerabilities to changes in the supplier's operational status.

The decision to maintain a single-source supply chain could be a strategic choice aimed at streamlining operations and ensuring quality consistency. Nonetheless, it is essential for Nutra-Med Packaging to assess the potential risks associated with this concentration and consider strategies to mitigate any adverse impacts on their supply chain resilience.

2Supply Chain Resilience

Nutra-Med Packaging LLC's supply chain exhibits a high degree of concentration, relying exclusively on PAR Formulations Private Limited for imports from India. This single-source dependency may limit the company's ability to diversify its supply chain and mitigate risks associated with potential disruptions. The absence of backup suppliers and limited formulation diversity could expose Nutra-Med Packaging to challenges in maintaining consistent product availability and quality.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation of pharmaceutical products. The FDA ensures that all imported drugs meet the standards for quality, safety, and effectiveness as stipulated by the Federal Food, Drug, and Cosmetic Act (FD&C Act). This includes verifying that drugs are not adulterated, misbranded, or unapproved.

The FDA's Regulatory Procedures Manual and Investigations Operations Manual provide detailed guidelines on import operations and actions, outlining the processes for evaluating and approving imported drugs. Additionally, the Automated Commercial Environment/International Trade Data System (ACE/ITDS) facilitates the electronic submission and processing of import data, streamlining the importation process.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States are governed by the FDA. All foreign drug establishments whose products are imported must register with the FDA and list all their drug products intended for commercial distribution in the U.S. This registration ensures that imported drugs comply with FDA standards and are subject to FDA oversight.

Good Manufacturing Practice (GMP) certification is crucial for ensuring the quality and safety of pharmaceutical products. The FDA recognizes GMP certifications from reputable organizations, including the European Union (EU) GMP, World Health Organization (WHO) GMP, and Pharmaceutical Inspection Co-operation Scheme (PIC/S). These certifications indicate that manufacturing facilities adhere to internationally recognized standards for pharmaceutical production.

Nutra MED Packaging Llc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Nutra-Med Packaging LLC's focus on importing finished pharmaceutical formulations, particularly in the respiratory and corticosteroid therapeutic categories, aligns with market demand for these medications. The company's top imported products include Methylprednisolone, Prednisolone, and Prednisone, which are commonly used to treat various respiratory conditions and inflammatory disorders. This strategic focus indicates Nutra-Med Packaging's commitment to providing essential medications that address prevalent health concerns in the United States.

The company's sourcing strategy, characterized by a single-source dependency on PAR Formulations Private Limited, suggests a

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — Nutra MED Packaging Llc

What products does Nutra MED Packaging Llc import from India?

Nutra MED Packaging Llc imports 3 pharmaceutical products across 2 categories. Top imports: Methylprednisolone ($500.0K), Prednisolone ($500.0K), Prednisone ($350.0K).

Who supplies pharmaceuticals to Nutra MED Packaging Llc from India?

Nutra MED Packaging Llc sources from 1 verified Indian suppliers. The primary supplier is Par Formulations Private Limited (100.0% of imports, $937.8K).

What is Nutra MED Packaging Llc's total pharmaceutical import value?

Nutra MED Packaging Llc's total pharmaceutical import value from India is $1.4M, based on 27 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Nutra MED Packaging Llc focus on?

Nutra MED Packaging Llc imports across 2 categories. The largest: Respiratory (63.0%), Corticosteroids (37.0%).

Get Full Nutra MED Packaging Llc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.